Clinical Study
Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience
Table 2
Previous immunosuppressive therapies in all included patients.
| Previous treatment | | CsA | 2 | AZA | 1 | MTX | 11 | Bolus of methylprednisolone i.v. | 2 | Biologic therapy | | First biologic drug used: | | IFX | 8 | ADA | 3 | ETN | 1 | Monotherapy/combined treatment | 4/9 | Second biologic drug used | | ADA | 6 | ETN | 1 | Monotherapy/combined treatment | 1/6 | Third biologic drug used | | Certolizumab | 1 | Abatacept | 2 | Monotherapy/combined treatment | 0/3 | Fourth biologic drug used | | ETN | 1 | Monotherapy/combined treatment | 0/1 |
|
|
CsA: cyclosporine A; AZA: azathioprine; MTX: methotrexate; IFX: infliximab; ADA: adalimumab; ETN: etanercept.
|